The cancer treatment industry has experienced a monumental shift through the successful development of KRAS-targeted medications, transforming what was once considered pharmaceutical science fiction into today's most dynamic therapeutic reality. This extraordinary achievement illustrates how relentless innovation can convert impossible molecular targets into transformative patient care...